The Monkeypox virus, or MPXV, is an emerging zoonotic disease that has garnered global attention in recent years due to its unexpected outbreaks outside its endemic regions.Initially recognized in forested areas of West and Central Africa, MPXV has now breached international boundaries, sparking concerns about public health and monkeypox prevention strategies.
Monkeypox virus-specific immunity plays a crucial role in the body’s response to the monkeypox virus (MPXV), particularly during infections with the clade IIb variant.Understanding how this immunity develops can illuminate the mechanisms behind the relatively mild disease observed in certain cases of monkeypox.
The antiviral drug tecovirimat has emerged as a focal point in the fight against the monkeypox virus, particularly as concerns rise about its spread across Africa.Recent clinical trial results have sparked debate over its effectiveness, especially against the clade I virus, which is known to pose a greater threat than its clade II counterpart.
Copyright © 2025 | WordPress Theme by MH Themes